ENTA

ENANTA PHARMACEUTICALS INC

Healthcare | Small Cap

-$0.81

EPS Forecast

$14.38

Revenue Forecast

Announcing earnings for the quarter ending 2026-09-30 soon

Proximilar's AI forecasts

EPS Forecast:

-$0.81

Revenue Forecast:

$14.38

EPS Surprise Forecast:

$0.013

Revenue Surprise Forecast:

$0

Post-release price volatility - Medium

Post-release Overnight Move:

±6.8%

Post-release 1-week Move:

±

Odds of beating consensus

Probability of beating EPS consensus:

54%

Probability of beating revenue consensus:

52%

Probability of beating both EPS & revs consensus:

34%

Probability of missing both EPS & revs consensus:

28%

Surprise rating (from -5 to 5)

How unusually large is the +/- surprise we forecast:

0

Beta (β)

Forward Looking Beta (β):

0.45

Earnings volatility

EPS standard deviation:

$0.40

Revenue standard deviation:

$5

As % of share price:

3.31% EXTREME UNCERTAINTY

As % of market cap:

1.51% HIGH

Confidence intervals and percentiles

EPS 95th %ile:

-$0.33

Revenue 95th %ile:

$21

EPS 75th %ile:

-$0.68

Revenue 75th %ile:

$16

EPS 25th %ile:

-$0.93

Revenue 25th %ile:

$13

EPS 5th %ile:

-$1.30

Revenue 5th %ile:

$9

Correlation of surprises (strength of relationship)

Correlation between EPS & revenue surprises:

37% MEDIUM

Earnings sensitivity to revenue surprises (slope of regression line)

Expected % of revenue surprise going to EPS:

82% VERY HIGH

Stock's bid-ask spread

Bid-ask per $10K:

$45

Bid-ask per Share:

$0.055